IPO Boutique keeps apprised of the active pipeline. Currently there are 72 active IPOs in the pipeline as of June 15, 2018. No SPACs or Unit Offerings are included. While the numbers may look diminished, we outlined why “looks may be perceiving” when it comes to the IPO pipeline in this article.
NEW FILINGS
IPO Boutique keeps apprised of the active pipeline. Currently there are 72 active IPOs in the pipeline as of June 22, 2018. No SPACs or Unit Offerings are included. While the numbers may look diminished, we outlined why “looks may be perceiving” when it comes to the IPO pipeline in this article.
NEW FILINGS
Company: Navios Maritime Containers L.P.
Symbol: TBD
Description: They are a growth-oriented international owner and operator of containerships.
Trade Date: TBD
Shares: TBD
Price Range: TBD
Underwriter(s): J.P. Morgan, BofA Merrill Lynch, Citigroup, Clarksons Platou Securities
Co-Manager(s): S. Goldman Advisors LLC
Filed: 6-15-18
Listed Cash Raise: $100m
Company: Coastal Financial Corporation
Symbol: CCB
Description: They are a bank holding company that operates through our wholly owned subsidiary, Coastal Community Bank.
Trade Date: TBD
Shares: TBD
Price Range: TBD
Underwriter(s): Keefe Bruyette & Woods, Hovde Group
Filed: 6-18-18
Listed Cash Raise: $30m
Company: First Western Financial, Inc.
Symbol: MYFW
Description: First Western Financial, Inc. is a financial holding company headquartered in Denver, Colorado.
Trade Date: TBD
Shares: TBD
Price Range: TBD
Underwriter(s): Keefe Bruyette & Woods, Stephens, Sandler O’ Neill
Filed: 6-19-18
Listed Cash Raise: $25m
Company: Tilray, Inc.
Symbol: TLRY
Description: They are pioneering the future of medical cannabis research, cultivation, processing and distribution globally, and we intend to become a leader in the adult-use cannabis market in Canada once legalized.
Trade Date: TBD
Shares: TBD
Price Range: TBD
Underwriter(s): Cowen, Roth Capital, Northland Capital
Filed: 6-20-18
Listed Cash Raise: $100m
Company: Cushman & Wakefield plc
Symbol: TBD
Description: They are a top three global commercial real estate services firm with an iconic brand and approximately 48,000 employees led by an experienced executive team.
Trade Date: TBD
Shares: TBD
Price Range: TBD
Underwriter(s): Morgan Stanley, J.P. Morgan, Goldman Sachs, UBS
Co-Manager(s): Barclays, BofA Merrill Lynch, Citigroup, Credit Suisse, William Blair, TPG Capital BD
Filed: 6-20-18
Listed Cash Raise: $100m
Company: Establishment Labs Holdings Inc.
Symbol: TBD
Description: They are a medical technology company focused on improving patient safety and aesthetic outcomes, initially in the breast aesthetics and reconstruction market.
Trade Date: TBD
Shares: TBD
Price Range: TBD
Underwriter(s): Jefferies, Cowen, BTIG
Filed: 6-21-18
Listed Cash Raise: $57.5m
Company: Cango Inc.
Symbol: CANG
Description: They are a leading automotive transaction service platform in China connecting dealers, financial institutions, car buyers and other industry participants.
Trade Date: TBD
Shares: TBD
Price Range: TBD
Underwriter(s):Morgan Stanley, BofA Merrill Lynch, Goldman Sachs (Asia)
Filed: 6-22-18
Listed Cash Raise: $300m
Company: Allakos Inc.
Symbol: ALLK
Description: They are are a clinical stage biotechnology company developing AK002, our wholly owned monoclonal antibody, for the treatment of various eosinophil and mast cell related diseases.
Trade Date: TBD
Shares: TBD
Price Range: TBD
Underwriter(s):Goldman Sachs, Jefferies
Co-Manager(s): William Blair
Filed: 6-22-18
Listed Cash Raise: $75m
Company: Rubius Therapeutics, Inc.
Symbol: RUBY
Description: They are pioneering the development of a new class of medicines, Red Cell Therapeutics, or RCTs.
Trade Date: TBD
Shares: TBD
Price Range: TBD
Underwriter(s):J.P. Morgan, Morgan Stanley, Jefferies, Leerink Partners
Filed: 6-22-18
Listed Cash Raise: $200m
Company: Crinetics Pharmaceuticals, Inc.
Symbol: CRNX
Description: They are a clinical stage pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors.
Trade Date: TBD
Shares: TBD
Price Range: TBD
Underwriter(s): J.P. Morgan, Leerink Partners, Piper Jaffray
Filed: 6-22-18
Listed Cash Raise: $86.25m
Company: Replimune Group, Inc.
Symbol: REPL
Description: They are a clinical-stage biotechnology company committed to applying our leading expertise in the field of oncolytic immunotherapy to transform the lives of cancer patients.
Trade Date: TBD
Shares: TBD
Price Range: TBD
Underwriter(s): J.P. Morgan, Leerink Partners, BMO Capital Markets
Filed: 6-22-18
Listed Cash Raise: $100m
Company: Constellation Pharmaceuticals, Inc.
Symbol: CNST
Description: They are a clinical-stage biopharmaceutical company using our expertise in epigenetics to discover and develop novel therapeutics that address serious unmet medical needs in patients with cancers associated with abnormal gene expression or drug resistance.
Trade Date: TBD
Shares: TBD
Price Range: TBD
Underwriter(s): J.P. Morgan, Jefferies, BMO Capital Markets
Co-Manager(s): Oppenheimer & Co.
Filed: 6-22-18
Listed Cash Raise: $86.25m
TERMS ADDED
Company: BJ’s Wholesale Club Holdings, Inc.
Symbol: BJ
Description: BJ’s Wholesale Club is a leading warehouse club operator on the East Coast of the United States.
Trade Date: 6/28
Shares: 37.5 million
Price Range: $15.00-$17.00
Underwriter(s): BofA Merrill Lynch, Deutsche Bank, Goldman Sachs, J.P. Morgan, Morgan Stanley, Citigroup, Jefferies, Wells Fargo
Co-Manager(s): Nomura, Baird, Guggenheim, Natixis, William Blair, Siebert Cisneros Shank & Co.
Terms Added: 6-18-18
Company: EverQuote, Inc
Symbol: EVER
Description: They operate the largest online marketplace for insurance shopping in the United States.
Trade Date: 6/28
Shares: 4.7 million
Price Range: $15.00-$17.00
Underwriter(s): J.P Morgan, BofA Merrill Lynch
Co-Manager(s): Canaccord Genuity, JMP Securities, Needham & Company Oppenheimer & Co., Raymond James, William Blair
Terms Added: 6-18-18
Company: Forty Seven, Inc.
Symbol: FTSV
Description: They are a clinical-stage immuno-oncology company focused on developing novel checkpoint therapies to activate macrophages in the fight against cancer
Trade Date: 6/28
Shares: 6.7 million
Price Range: $14.00-$16.00
Underwriter(s): Morgan Stanley, Credit Suisse
Co-Manager(s): BTIG, Canaccord Genuity, Oppenheimer & Co.
Terms Added: 6-18-18
Company: Translate Bio, Inc.
Symbol: TBIO
Description: They are a leading messenger RNA, or mRNA, therapeutics company developing a new class of potentially transformative medicines to treat diseases caused by protein or gene dysfunction
Trade Date: 6/28
Shares: 7.7 million
Price Range: $12.00-$14.00
Underwriter(s): Citigroup, Leerink Partners, Evercore ISI
Terms Added; 6-18-18
Company: BrightView Holdings, Inc.
Symbol: BV
Description: They are the largest provider of commercial landscaping services in the United States, with revenues more than 10 times those of their next largest commercial landscaping competitor.
Trade Date: 6/28
Shares: 21.3 million
Price Range: $22.00-$25.00
Underwriter(s): Goldman Sachs, J.P. Morgan, KKR, UBS Investment Bank, Baird, Credit Suisse Macquarie Capital, Jefferies, Mizuho Securities, Morgan Stanley, RBC Capital Markets
Co-Manager(s): Nomura, Stifel, William Blair, Moelis & Company, SMBC Nikko
Terms Added: 6-18-18
Company: Tricida, Inc.
Symbol: TCDA
Description: Their goal is to slow the progression of chronic kidney disease, or CKD, through the treatment of metabolic acidosis.
Trade Date: 6/28
Shares: 10.3 million
Price Range: $16.00-$18.00
Underwriter(s): Goldman Sachs, J.P. Morgan, Cowen
Terms Added: 6-18-18
Company: The Lovesac Company
Symbol: LOVE
Description: They are a technology driven, omni-channel company that designs, manufactures and sells unique, high quality furniture comprised of modular couches called Sactionals and premium foam beanbag chairs called Sacs.
Trade Date: Week of 6/25
Shares: 3 million
Price Range: $13.00-$15.00
Underwriter(s): Roth Capital Partners
Co-Manager: Craig Hallum
Terms Added: 6-18-18
Company: Domo, Inc.
Symbol: DOMO
Description: Domo is an operating system that powers a business, enabling all employees to access real-time data and insights and take action from their smartphone.
Trade Date: 6/29
Shares: 9.2 million
Price Range: $19.00-$22.00
Underwriter(s): Morgan Stanley, Allen & Company, Credit Suisse, UBS Investment Bank
Co-Manager(s): William Blair, JMP Securities, Cowen
Filed: 6-18-18
English
Arabic
Chinese (Simplified)
Dutch
French
German
Italian
Portuguese
Russian
Spanish